News | Radiation Oncology | December 30, 2015

ASTRO Launches Template to Help Radiation Oncologists Guide Cancer Survivors Through Ongoing Care

A new template published by the American Society for Radiation Oncology (ASTRO) standardizes and streamlines the creation of patient-focused plans for long-term cancer survivor care following radiation therapy (RT). As the number of cancer patients and survivors in the U. S. continues to grow – the American Cancer Society predicts a 37 percent increase in the number of cancer patients surviving five years or longer over the next decade – so does the need for greater attention to long-term survivorship care.

The template and related research papers, “Development of a Standard Survivorship Care Plan for Radiation Oncologists” and “U.S. Radiation Oncology Practice Patterns for Post-Treatment Survivor Care,” are published in Practical Radiation Oncology (PRO), the official clinical journal of ASTRO. The template was developed to coordinate post-treatment care for cancer survivors among the various contributors to their care, including primary care providers (PCPs) and oncology specialists (radiation, medical and surgical), as well as patients themselves.

“Factors such as earlier detection of cancer, increasingly effective treatment options, and an aging population lead to a growing number of cancer survivors and, ultimately, a need to educate and empower these individuals for their ongoing care,” said ASTRO chair Bruce D. Minsky, M.D., FASTRO. “The ASTRO template is designed to foster better coordination of post-treatment care for cancer survivors, including greater clarity in the dialogue between radiation oncologists and PCPs for issues such as less common side effects that may appear well after treatment is complete.”

The framework also enables practices to meet new accreditation requirements set by the American College of Surgeons Commission on Cancer (CoC). In response to a 2006 recommendation from the Institutes of Medicine that cancer patients be provided with a survivorship care plan (SCP) following treatment, CoC issued a mandate that cancer programs provide SCPs for all curative cancer patients by 2019 to maintain accreditation.

The new CoC requirement may necessitate changes for the majority of radiation oncology programs, according to data from a March 2014 survey of ASTRO members, which include nearly all practicing radiation oncologists in the U.S. The survey found that only 40 percent and 19 percent of respondents used SCPs for curative and palliative patients, respectively. Primary barriers to implementation included cost and the lack of a standardized, comprehensive SCP framework suited to patients who received RT. Nearly 80 percent of the RT providers that reported using SCPs relied on a framework developed internally within their practice, indicating that different patients may receive different types of information depending on where they receive treatment.

“This two-page template facilitates consistency in SCPs across the discipline and also reduces the time and effort required by providers to complete each individual plan,” said Ronald Chen, M.D., MPH, an associate professor in radiation oncology at the University of North Carolina at Chapel Hill and lead author on the manuscript that includes the template. “The field of radiation oncology has a long tradition of creating treatment summaries for each patient, even before the Institute of Medicine recommended survivorship care plans in 2006. This radiation-oncology specific template will serve a dual purpose as both a traditional radiation oncology treatment summary and a plan for survivorship care that meets CoC requirements – thus reducing the burden on radiation oncologists from having to create two documents for each patient.” Chen was the chair of ASTRO's Clinical, Translational and Basic Science Advisory Committee, the group that examined current adoption levels of SCPs and developed the template to standardize them in the future.

While many radiation oncologists provide their patients with follow-up material such as diagnosis and treatment summaries, contacts for ancillary services such as financial or nutritional counselling, and information on potential late treatment effects, the SCP template coordinates these components in a central, plain language document. The template includes both elements required by CoC in SCPs, namely a summary of past treatment and directions for future care. The treatment summary outlines the survivor’s diagnosis and stage information; treatment details such as the site, dosage and schedule of RT; and contact information for providers who delivered the treatment. The plan for follow-up care covers anticipated toxicities from RT, expected course of recovery from treatment-related toxicities, possible functional and/or social limitations, recommendations for preventative measures and behaviors, cancer information resources, and referrals to supportive care providers.

For more information: www.astro.org

Related Content

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects
News | Radiation Therapy | October 23, 2018
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus,...
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them better at the jobs only they can do, said speakers at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas.
Feature | Artificial Intelligence | October 22, 2018 | By Greg Freiherr
Artificial intelligence (AI) will not force specialists in radiation oncology from their jobs but rather make them be
News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...

Image courtesy of Vital Images

News | ASTRO | October 22, 2018
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one
Fewer, larger individual doses of radiation lead to similar adverse effects to normal tissue after 10 years as with conventional radiation therapy for early breast cancer
News | ASTRO | October 22, 2018
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer,
Patients whose cancer has not spread far past the lungs may benefit from targeting tumor sites with radiation or surgery after initial treatment, according to ASTRO study
News | ASTRO | October 21, 2018
Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t